These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2777200)

  • 1. Different insulin antibody formation in diabetic patients treated with crystallized or highly purified insulins is a transient phenomenon.
    Keilacker H; Rjasanowski I; Woltanski KP; Kohnert KD; Ziegler M; Michaelis D
    Horm Metab Res; 1989 Jul; 21(7):398-9. PubMed ID: 2777200
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin antibodies in diabetics receiving a single type of insulin.
    Mincu I; Cheţa D
    Med Interne; 1982; 20(1):9-13. PubMed ID: 6765628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic response to mono-component insulin in newly diagnosed diabetic patients.
    Devlin JG; Parameswaran V
    Ir Med J; 1975 Jun; 68(12):301-5. PubMed ID: 1140940
    [No Abstract]   [Full Text] [Related]  

  • 4. The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies.
    Anderson OO
    Acta Endocrinol (Copenh); 1975 Apr; 78(4):723-35. PubMed ID: 1173962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals.
    Schernthaner G; Borkenstein M; Fink M; Mayr WR; Menzel J; Schober E
    Diabetes Care; 1983; 6 Suppl 1():43-8. PubMed ID: 6343038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type].
    Andreani D; Iavicoli M; Colletti A; Menzinger G
    Folia Endocrinol; 1972 Dec; 25(6):516-39. PubMed ID: 4581824
    [No Abstract]   [Full Text] [Related]  

  • 7. [Proceedings: Formation of anti-insulin antibodies IgG in diabetic patients treated with conventional insulin monocomposed or monospecific].
    Weber HU; Sourisseau D; Zahnd GR
    Helv Med Acta; 1974 May; 37(5-6):367. PubMed ID: 4410557
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin antibody formation. I. The influence of age, sex, infections, insulin dosage and regulation of diabetes.
    Andersen OO
    Acta Endocrinol (Copenh); 1972 Sep; 71(1):126-40. PubMed ID: 4678008
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experiences with monocomponent insulins].
    Bruni Bocher K; Giolitti A; Turco GL; Benedetto P; Bruni B
    Minerva Med; 1975 Mar; 66(19):909-30. PubMed ID: 1124144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to the insulin receptor: clinical and molecular aspects.
    Kahn CR
    Fed Proc; 1979 Nov; 38(12):2607-9. PubMed ID: 499577
    [No Abstract]   [Full Text] [Related]  

  • 11. Behaviour of insulin antibodies in diabetics treated with different insulins.
    Mincu I; Cheţa D; Ionescu-Tîrgovişte C; Mirodon Z; Sîntu E
    Med Interne; 1980; 18(4):347-52. PubMed ID: 7006044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating insulin antibodies during therapy with highly purified neutrally buffered insulins including desphe insulins. Report of a prospective study with 40 cases.
    Kühnau J; Rüdiger H; Goetz K
    Exp Clin Endocrinol; 1984 Apr; 83(2):161-7. PubMed ID: 6373318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the antibody anti-insulin titer using Christiansen's radioimmunoelectrophoresis in clinical diabetology].
    Bruni Bocher K; Castellazzi R; D'Adda A; Gamba S; Giolitti A; Rittatore R; Turco GL; Bruni B
    Ann Osp Maria Vittoria Torino; 1975; 18(1-6):26-52. PubMed ID: 1242089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monocomponet insulins].
    Rodríguez-Miñón JL
    Rev Clin Esp; 1978 Mar; 148(6):579-82. PubMed ID: 663334
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunogenicity of bovine, porcine and semisynthetic human insulin.
    Venekamp WJ; van der Hooft JC; Jacobsen L; van Schaik CL
    Neth J Med; 1985; 28 Suppl 1():57-8. PubMed ID: 3892343
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunologic problems of diabetes mellitus].
    Carta Q; Bumma C; Lanfranco G
    Minerva Med; 1974 Jan; 65(1):60-4. PubMed ID: 4425182
    [No Abstract]   [Full Text] [Related]  

  • 17. [Late complications of diabetes mellitus-consequence of immunologic reactions?].
    Bemm H; Lohmann D
    Allerg Immunol (Leipz); 1974-1975; 20-21(1):15-20. PubMed ID: 4282823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous insulin needs. Relationship with duration of diabetes, C-peptidemia, insulin antibodies, and retinopathy.
    Haumont D; Dorchy H; Toussaint D; Despontin M
    Helv Paediatr Acta; 1982 May; 37(2):143-50. PubMed ID: 7047466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin antibodies in diabetic children treated with highly purified porcine NPH insulin. Comparison of results obtained by three methods of insulin antibody determination.
    Mäkelä AL; Akerblom HK; Mäkelä P
    Diabete Metab; 1982 Dec; 8(4):341-8. PubMed ID: 7160521
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of circulating insulin and proinsulin-binding antibodies in autoimmune hypoglycemia.
    Goldman J; Baldwin D; Rubenstein AH; Klink DD; Blackard WG; Fisher LK; Roe TF; Schnure JJ
    J Clin Invest; 1979 May; 63(5):1050-9. PubMed ID: 447827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.